• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » PureTech Health’s Daphne Zohar named EY Entrepreneur Of The Year 2016

PureTech Health’s Daphne Zohar named EY Entrepreneur Of The Year 2016

June 28, 2016
CenterWatch Staff

Daphne Zohar, co-founder and chief executive officer of PureTech Health, a cross-disciplinary biotech company tackling fundamental healthcare needs in disruptive ways, was named the EY Entrepreneur Of The Year 2016 in the New England program. The awards program, which is celebrating its 30th year, recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

“It’s an honor to be recognized among this distinguished group of business leaders and innovators,” said Zohar. “The New England region has truly become a hub for fostering an entrepreneurial spirit and new ideas.”

Founded and produced by EY, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation. In New England, sponsors also include fama PR, Goodwin Procter, the Isenberg School of Management at the University of Massachusetts Amherst, Nixon Peabody, True, Chatham Financial, Empire Valuation, Morgan Lewis and T3 Advisors.

Zohar is co-founder and chief executive officer of PureTech Health and a member of the company’s board of directors. Zohar is an entrepreneur who built a new kind of biotech company in PureTech. Zohar assembled a leading team to help implement her vision, and she has attracted over $450 million to the company and its businesses.

Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources, including BioWorld, MIT's Technology Review, the Boston Globe and Scientific American. She sits on the boards of PureTech Health, The Sync Project, Akili Interactive Labs, Follica, Karuna Pharmaceuticals and Tal Medical. She also sits on the Technology Development Fund advisory board at Children's Hospital Boston and is an editorial advisor to Xconomy, a national news company.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing